BridgeBio Pharma 8K Filing
BridgeBio Pharma files 8K with SEC, disclosing other events and financial statements. Filing may contain material information for investors.
Filed: 2026-05-27 AccNo: 0001140361-26-022979 Size: 184 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits